ZHANG BEILI,KRAWIEC MARIUSZ,LUISI BRIAN,MEDEK ALES
申请号：
NZ59970310
公开号：
NZ599703A
申请日:
2010.10.21
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
The disclosure relates to N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide characterized as Form A-HCl, which is characterized by the following peaks in an X-ray powder diffraction pattern selected from the group consisting of a peak at about 7.1 degrees, a peak at about 21.2 degrees, a peak from about 6.9 to about 7.3 degrees, a peak from about 8.0 to about 8.4 degrees, a peak from about 13.9 to about 14.3 degrees, a peak from about 21.0 to about 21.4 degrees, a peak from about 14.5 to about 14.9 degrees, a peak from about 16.2 to about 16.6 degrees, a peak from about 18.5 to about 18.9 degrees, and a peak from about 22.6 to about 23.0 degrees.
